TREATMENT WITH RUXOLITINIB IN MYELOFIBROSIS AND VERA POLYTETHEMIA: EXPERIENCE IN A COMARCAL HOSPITAL

被引：0
|
作者：
Mas Esteve, E. [1 ]
Claros Barrachina, N. [1 ]
Bernat Pablo, S. [1 ]
Guinot Martinez, M. [1 ]
机构：
[1] Hosp Univ La Plana Vila Real, Villarreal, Spain
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB- 096
引用
收藏
页码：357 / 358
页数：2
相关论文
共 50 条
  • [21] RUXOLITINIB IN VERA POLYCYTHEMIA AND MYELOFIBROSIS: EFFICACY AND SAFETY IN CLINICAL ASSISTANCE PRACTICE
    Ruiz Mercado, M.
    Mata Vazquez, M., I
    Moreno Beltran, M. E.
    Casanova Espinosa, M.
    Rueda Dominguez, A.
    Medina Perez, A.
    HAEMATOLOGICA, 2018, 103 : 355 - 356
  • [22] ASH 2016: New clinical Data on Ruxolitinib in Myelofibrosis and Polycythaemia vera
    Nothing, Pia
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 (02) : 118 - 118
  • [23] REAL -WORLD EVIDENCE OF RUXOLITINIB IN THE TREATMENT OF MYELOFIBROSIS: EXPERINCE OF A PORTUGUESE HOSPITAL CENTER
    Almeida, A.
    Alnajjar, K.
    Viriato, D.
    VALUE IN HEALTH, 2016, 19 (07) : A577 - A577
  • [24] Ruxolitinib treatment for GvHD in patients with myelofibrosis
    Y Mori
    K Ikeda
    T Inomata
    G Yoshimoto
    N Fujii
    H Ago
    T Teshima
    Bone Marrow Transplantation, 2016, 51 : 1584 - 1587
  • [25] Recommendations on the use of ruxolitinib for the treatment of myelofibrosis
    Devos, Timothy
    Selleslag, Dominik
    Zachee, Pierre
    Benghiat, Fleur Samantha
    HEMATOLOGY, 2018, 23 (04) : 194 - 200
  • [26] Ruxolitinib treatment for GvHD in patients with myelofibrosis
    Mori, Y.
    Ikeda, K.
    Inomata, T.
    Yoshimoto, G.
    Fujii, N.
    Ago, H.
    Teshima, T.
    BONE MARROW TRANSPLANTATION, 2016, 51 (12) : 1584 - 1587
  • [27] A case of pachydermaperiostosis with myelofibrosis and treatment with ruxolitinib
    Deniz, Rabia
    Ezircan-Alay, Merve
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (01) : 324 - 326
  • [28] Myelofibrosis Treatment Beyond Ruxolitinib: A Single-center Experience With Momelotinib and Pacritinib
    Medawar, Georgio
    Baratam, Praneeth
    Green, Kimberly
    Smith, Deidra
    Coltoff, Alexander
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S422 - S423
  • [29] Second primary malignancies in patients receiving treatment with ruxolitinib for myelofibrosis - a regional experience
    Schofield, J.
    Wells, R.
    Nicholson, T.
    Butt, N. M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 77 - 77
  • [30] Experience with ruxolitinib in the treatment of polycythaemia vera (vol 8, pg 139, 2017)
    Alimam, Samah
    Harrison, Claire
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2017, 8 (09) : 273 - 273
12345